We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RRC icon
1101
Range Resources
RRC
$8.85B
$2.62M ﹤0.01%
104,553
-173,897
-62% -$4.76M
U icon
1102
Unity
U
$13.3B
$2.61M ﹤0.01%
91,217
+5,900
+7% +$185K
HPE icon
1103
Hewlett Packard
HPE
$63.8B
$2.6M ﹤0.01%
162,715
+10,745
+7% +$158K
CPNG icon
1104
Coupang
CPNG
$28.6B
$2.6M ﹤0.01%
176,385
-80,027
-31% -$1.41M
HAL icon
1105
Halliburton
HAL
$26.8B
$2.59M ﹤0.01%
65,950
+15,793
+31% +$559K
PI icon
1106
Impinj
PI
$3.97B
$2.57M ﹤0.01%
23,569
-794
-3% -$83.6K
TXNM
1107
TXNM Energy Inc
TXNM
$6.44B
$2.55M ﹤0.01%
55,000
+16,608
+43% +$791K
ACAD icon
1108
Acadia Pharmaceuticals
ACAD
$4.35B
$2.55M ﹤0.01%
160,000
-2,964
-2% -$46.3K
TARS icon
1109
Tarsus Pharmaceuticals
TARS
$2.62B
$2.54M ﹤0.01%
172,908
DRVN icon
1110
Driven Brands
DRVN
$2.37B
$2.53M ﹤0.01%
92,780
-60,601
-40% -$1.81M
LOPE icon
1111
Grand Canyon Education
LOPE
$3.84B
$2.52M ﹤0.01%
23,888
+23,147
+3,124% +$2.31M
IQV icon
1112
IQVIA
IQV
$35.6B
$2.52M ﹤0.01%
12,312
+3,881
+46% +$787K
ATVI
1113
DELISTED
Activision Blizzard
ATVI
$2.51M ﹤0.01%
32,772
+4,415
+16% +$328K
BKR icon
1114
Baker Hughes
BKR
$60.1B
$2.48M ﹤0.01%
83,894
-14,654
-15% -$404K
CLDT
1115
Chatham Lodging
CLDT
$643M
$2.47M ﹤0.01%
201,455
+1,560
+0.8% +$19.2K
AMKR icon
1116
Amkor Technology
AMKR
$15B
$2.46M ﹤0.01%
102,600
XPO icon
1117
XPO
XPO
$24.4B
$2.46M ﹤0.01%
73,845
-63,528
-46% -$2.14M
TOST icon
1118
Toast
TOST
$17.9B
$2.45M ﹤0.01%
+135,772
New +$2.55M
LAMR icon
1119
Lamar Advertising Co
LAMR
$16.3B
$2.45M ﹤0.01%
25,920
-599
-2% -$55.4K
AHCO icon
1120
AdaptHealth
AHCO
$1.49B
$2.42M ﹤0.01%
126,072
-59,390
-32% -$1.26M
NWS icon
1121
News Corp Class B
NWS
$16.8B
$2.42M ﹤0.01%
131,255
+21,677
+20% +$382K
POR icon
1122
Portland General Electric
POR
$5.93B
$2.41M ﹤0.01%
49,176
-685
-1% -$31.7K
RIGL icon
1123
Rigel Pharmaceuticals
RIGL
$692M
$2.4M ﹤0.01%
160,000
HSY icon
1124
Hershey
HSY
$36.6B
$2.39M ﹤0.01%
10,330
+568
+6% +$131K
HII icon
1125
Huntington Ingalls Industries
HII
$11.4B
$2.39M ﹤0.01%
10,366
-163
-2% -$38.4K

Similar funds

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.